Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT04719702
Eligibility Criteria:
Phase 1: Participants are eligible for participation in this study when they meet all the following criteria:
* Adults;
* with advanced cancer;
* and a limited life expectancy (1- 2 months);
* according the health care team, intractable distress caused by one or more refractory symptoms can be expected or is present during the hospitalization.
Participants can enter Phase 2 of this study when fulfilling the following preconditions:
* inclusion criteria for phase 1 are met and informed consent is given by the participant;
* participant is suffering from intractable distress caused by one or more refractory symptoms according the health care team and/or participant and relatives;
* sedative medication is started with the aim to relieve burden of otherwise intractable suffering (palliative sedation)
Exclusion Criteria:
* a potential participant is unable to give informed consent;
* a potential participant is unable to speak and read in the native language of the participating country.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04719702
Study Brief:
Protocol Section:
NCT04719702